Polarized Light Therapy in Patients With CREST Syndrome.
NCT ID: NCT06621628
Last Updated: 2024-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2023-04-10
2024-07-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Bioptron Light on Carpal Tunnel Syndrome(BLCTS)
NCT06209918
Efficacy of Laser Acupuncture on Carpal Tunnel Syndrome Following Hand Flexor Tendon Repair
NCT07014774
Comparison of Rest Splints vs High-Intensity Laser Therapy in Carpal Tunnel Syndrome
NCT07294157
Effect of Russian Current on Hand Grip Strength and Functional Outcome After Carpal Tunnel Release
NCT07166029
Effects of High Intensity Laser on Mechanical and Physiological Findings in Pregnant Women With Carpal Tunnel Syndrome
NCT04969393
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group A
This group included 20 patients who had CREST syndrome with scleroderma in the dorsum of hands and who received the BLT with traditional physical therapy program (stretching, strengthening and active exercise) patients received 3 sessions per week for 12 weeks (3 months),time of session is 15 minutes.
stretching, strengthening exercises and active exercises
Bioptron light therapy device, resisted exercises and stretching exercises
study group B
This group included 20 patients who have CREST syndrome with scleroderma in the dorsum of hands and who received resisted exercise with traditional physical therapy program (stretching, strengthening and active exercise) patients received 3 sessions per week for 12 weeks (3 months), time of session is 15 minutes
stretching, strengthening exercises and active exercises
Bioptron light therapy device, resisted exercises and stretching exercises
study group C
This group included 20 patients who had CREST syndrome with scleroderma in the dorsum of hands and who received combination of (bipotron light therapy and resisted exercise) with traditional physical therapy program (stretching, strengthening and active exercise) exercise program (stretching, strengthening and active exercise).patients received 3 sessions per week for 12weeks (3 months), time of session is 15 minutes
stretching, strengthening exercises and active exercises
Bioptron light therapy device, resisted exercises and stretching exercises
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stretching, strengthening exercises and active exercises
Bioptron light therapy device, resisted exercises and stretching exercises
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who had hand involvement of patients with CREST syndrome particularly dorsum of the hand.
* All patients were conscious.
* All patients were randomly chosen (male and female).
Exclusion Criteria
* Patients those familiar with the BLT and resisted exercise via the hand grip strengthener.
* Patients with hemorrhage specially hemorrhage of digestive system and those with bleeding per rectum.
* Patients with severe fungal diseases and acute viral diseases.
* Patients with active tuberculosis and tumors as well as those with peacemakers.
* Patients with polyneuropathy.
* Patients with thyroid problems
16 Years
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New Ismailia National University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Abdel Moeim Abo EL Ros
Lecturer of Physical Therapy for Pediatrics and its Surgeries
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zakaria E Mowafy, Ph.D
Role: STUDY_DIRECTOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Khadra Mohamed Ali
Ismailia, , Egypt
Mohamed Abdel Moenem Abo El Ros
Ismailia, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/004063
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.